We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
(-11%)
Cap. Flow
-$3.05B
Cap. Flow
% of AUM
-17.25%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$113M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$106M |
| 3 |
Merck
MRK
|
+$95.9M |
| 4 |
Baidu
BIDU
|
+$85.8M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$229M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 15.39% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 10.48% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
926
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.01M | 0.01% |
+33,753
| New | +$943K |
|
927
Martin Midstream Partners
MMLP
$95.9M
| $1M | 0.01% |
+72,737
| New | +$1.06M |
|
|
WCN
928
Waste Connections
WCN
$42B
| $1M | 0.01% |
13,278
-174,489
| -93% | -$13M |
|
|
TPC
929
Tutor Perini Cor
TPC
$5.21B
| $999K | 0.01% |
54,122
+43,753
| +422% | +$900K |
|
|
AMTD
930
DELISTED
TD Ameritrade Holding Corp
AMTD
| $993K | 0.01% |
18,117
-94,710
| -84% | -$5.64M |
|
|
FFWM
931
DELISTED
First Foundation Inc
FFWM
| $986K | 0.01% |
+53,171
| New | +$1.01M |
|
932
Coca-Cola Europacific Partners
CCEP
$47.9B
| $980K | 0.01% |
24,116
-30,004
| -55% | -$1.18M |
|
933
Ryder
R
$10.1B
| $978K | 0.01% |
+13,610
| New | +$954K |
|
934
Coeur Mining
CDE
$17.9B
| $976K | 0.01% |
+128,423
| New | +$1.04M |
|
935
FerroAtlántica
GSM
$839M
| $975K | 0.01% |
113,762
-140,332
| -55% | -$1.47M |
|
936
Gran Tierra Energy
GTE
$317M
| $975K | 0.01% |
28,256
-157,538
| -85% | -$5.04M |
|
937
Bridgewater Bancshares
BWB
$603M
| $973K | 0.01% |
76,507
+25,307
| +49% | +$329K |
|
938
Origin Bancorp
OBK
$1.66B
| $965K | 0.01% |
+23,583
| New | +$918K |
|
939
Enerpac Tool Group
EPAC
$1.93B
| $961K | 0.01% |
+32,736
| New | +$812K |
|
940
Telkom Indonesia
TLK
$14.9B
| $959K | 0.01% |
+36,886
| New | +$966K |
|
|
AUTL
941
Autolus Therapeutics
AUTL
$562M
| $954K | 0.01% |
+35,600
| New | +$941K |
|
942
McCormick & Company Non-Voting
MKC
$14.2B
| $952K | 0.01% |
+16,394
| New | +$861K |
|
943
Intrepid Potash
IPI
$469M
| $945K | 0.01% |
+23,045
| New | +$1.01M |
|
|
MAGN
944
Magnera Corp
MAGN
$460M
| $942K | 0.01% |
+3,698
| New | +$915K |
|
945
Inspire Medical Systems
INSP
$1.74B
| $933K | 0.01% |
+26,150
| New | +$844K |
|
946
Silicon Motion
SIMO
$8.68B
| $929K | 0.01% |
17,568
-17,925
| -51% | -$880K |
|
|
DOCU
947
DocuSign
DOCU
$11.5B
| $923K | 0.01% |
+17,432
| New | +$880K |
|
|
QTS
948
DELISTED
QTS REALTY TRUST, INC.
QTS
| $923K | 0.01% |
+23,379
| New | +$863K |
|
|
MGP
949
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $922K | 0.01% |
30,285
-708,738
| -96% | -$20.4M |
|
950
Opko Health
OPK
$1.02B
| $908K | 0.01% |
+193,098
| New | +$732K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.
- Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
- Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
- Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
- Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
- Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
- Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
- Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.
Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.